Association of Impaired Fasting Glucose and Diabetes with SARS-CoV-2 Spike Antibody Titers after the BNT162b2 Vaccine among Health Care Workers in a Tertiary Hospital in Japan

por Islam, Zobida, Yamamoto, Shohei, Mizoue, Tetsuya, Tanaka, Akihito, Oshiro, Yusuke, Inamura, Natsumi, Konishi, Maki, Ozeki, Mitsuru, Sugiura, Wataru, Ohmagari, Norio
Publicado 2022

Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients

por Islam, Zobida, Yamamoto, Shohei, Mizoue, Tetsuya, Oshiro, Yusuke, Inamura, Natsumi, Nemoto, Takeshi, Konishi, Maki, Ozeki, Mitsuru, Sugiura, Wataru, Ohmagari, Norio
Publicado 2022

Sex‐associated differences between BMI and SARS‐CoV‐2 antibody titers following the BNT162b2 vaccine

por Yamamoto, Shohei, Mizoue, Tetsuya, Tanaka, Akihito, Oshiro, Yusuke, Inamura, Natsumi, Konishi, Maki, Ozeki, Mitsuru, Miyo, Kengo, Sugiura, Wataru, Sugiyama, Haruhito, Ohmagari, Norio
Publicado 2022

Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants

por Mizoue, Tetsuya, Yamamoto, Shohei, Oshiro, Yusuke, Inamura, Natsumi, Nemoto, Takashi, Horii, Kumi, Okudera, Kaori, Konishi, Maki, Ozeki, Mitsuru, Sugiyama, Haruhito, Aoyanagi, Nobuyoshi, Sugiura, Wataru, Ohmagari, Norio
Publicado 2023

Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine

por Yamamoto, Shohei, Oshiro, Yusuke, Inamura, Natsumi, Nemoto, Takashi, Horii, Kumi, Okudera, Kaori, Konishi, Maki, Ozeki, Mitsuru, Mizoue, Tetsuya, Sugiyama, Haruhito, Aoyanagi, Nobuyoshi, Sugiura, Wataru, Ohmagari, Norio
Publicado 2023

Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants

por Mizoue, Tetsuya, Yamamoto, Shohei, Konishi, Maki, Oshiro, Yusuke, Inamura, Natsumi, Nemoto, Takashi, Ozeki, Mitsuru, Horii, Kumi, Okudera, Kaori, Sugiyama, Haruhito, Aoyanagi, Nobuyoshi, Sugiura, Wataru, Ohmagari, Norio
Publicado 2022

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2

por Yamamoto, Shohei, Matsuda, Kouki, Maeda, Kenji, Oshiro, Yusuke, Inamura, Natsumi, Mizoue, Tetsuya, Konishi, Maki, Takeuchi, Junko S., Horii, Kumi, Ozeki, Mitsuru, Sugiyama, Haruhito, Mitsuya, Hiroaki, Sugiura, Wataru, Ohmagari, Norio
Publicado 2023

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan

por Yamamoto, Shohei, Tanaka, Akihito, Oshiro, Yusuke, Ishii, Masamichi, Ishiwari, Hironori, Konishi, Maki, Matsuda, Kouki, Ozeki, Mitsuru, Miyo, Kengo, Maeda, Kenji, Mizoue, Tetsuya, Sugiura, Wataru, Mitsuya, Hiroaki, Sugiyama, Haruhito, Ohmagari, Norio
Publicado 2021

Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Mat...

por Yamamoto, Shohei, Maeda, Kenji, Matsuda, Kouki, Tanaka, Akihito, Horii, Kumi, Okudera, Kaori, Takeuchi, Junko S, Mizoue, Tetsuya, Konishi, Maki, Ozeki, Mitsuru, Sugiyama, Haruhito, Aoyanagi, Nobuyoshi, Mitsuya, Hiroaki, Sugiura, Wataru, Ohmagari, Norio
Publicado 2021

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

por Yamamoto, Shohei, Matsuda, Kouki, Maeda, Kenji, Horii, Kumi, Okudera, Kaori, Oshiro, Yusuke, Inamura, Natsumi, Takeuchi, Junko S., Konishi, Maki, Ozeki, Mitsuru, Mizoue, Tetsuya, Sugiyama, Haruhito, Aoyanagi, Nobuyoshi, Mitsuya, Hiroaki, Sugiura, Wataru, Ohmagari, Norio
Publicado 2023